FDA approves Novo Nordisk's diabetes pill as first-line therapy | HealthCare Middle East & Africa Magazine
Novo Nordisk Invests $130M in New Diabetes Lab Facility in Denmark
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
Novo Nordisk NC Sites to Supply Newly Approved Diabetes Drug | North Carolina Biotechnology Center
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial | Fierce Biotech
Pill version of obesity drug reduced weight almost 13% in new trial
Diabetesmedikament: EMA warnt vor Nebenwirkungen bei Diabetes-Präparaten von Novo Nordisk
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement — MedWatch
Novo Nordisk's diabetes drug Ozempic back in supply in US after months of shortage | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/VQNBXFIJPRIBPPDP7NSEMHRNNQ.jpg "Novo Nordisk sees faster profit growth on diabetes drug Ozempic | Reuters")
Novo Nordisk sees faster profit growth on diabetes drug Ozempic | Reuters
Novo Nordisk comments on role of off-label use in Ozempic shortfall
Novo Nordisk's Positive Phase III Data for Oral Diabetic Drug Heats Up the Competition | BioSpace
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst | Fierce Pharma
Novo Nordisk Gets EU Nod for Diabetes Drug | CHEManager
Russia to Receive Popular Diabetes Drug Ozempik from Novo Nordisk by December 2023
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
With growing popularity of new weight loss drugs, doctors emphasize potential risks - ABC News
Novo Nordisk launches anti-diabetes pill semaglutide in India - The Economic Times
Marktanalyse für Arzneimittel zur Behandlung von Diabetes – Branchenbericht – Trends, Größe und Anteil
Latest news
Drugs developed to treat diabetes may offer new approach against Alzheimer's | The Japan Times
Novo Nordisk gets nod for oral diabetes drug
